CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
5.50
-0.02 (-0.36%)
At close: Jun 17, 2025, 4:00 PM
5.49
-0.01 (-0.18%)
After-hours: Jun 17, 2025, 7:59 PM EDT
CureVac Market Cap
CureVac has a market cap or net worth of $1.24 billion as of June 17, 2025. Its market cap has increased by 46.45% in one year.
Market Cap
1.24B
Enterprise Value
805.08M
1-Year Change
46.45%
Ranking
Category
Stock Price
$5.50
Market Cap Chart
Since the IPO on August 14, 2020, CureVac's market cap has decreased from $9.84B to $1.24B, a decrease of -87.41%. That is a compound annual growth rate of -34.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2025 | 1.24B | 62.50% |
| Dec 31, 2024 | 764.91M | -18.86% |
| Dec 29, 2023 | 942.72M | -17.82% |
| Dec 30, 2022 | 1.15B | -82.12% |
| Dec 31, 2021 | 6.42B | -55.14% |
| Dec 31, 2020 | 14.31B | 45.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.57B |
| Johnson & Johnson | 377.99B |
| Novo Nordisk | 355.28B |
| AbbVie | 337.52B |
| Regencell Bioscience Holdings | 294.27B |
| UnitedHealth Group | 284.42B |
| Abbott Laboratories | 235.96B |
| Novartis AG | 234.52B |